Measurement of TNF-α transcription showed that TNF-α mRNA levels were significantly increased in the PBMC from IBD patients following continuous IFX therapy compared to those receiving short term IFX (initial therapy) (Figure 4C) (p < 0.05). The gene discussed is TNF; the disease is inflammatory bowel disease.